Loading
Please wait while we load your information from QuoteMedia.
Loading
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
As of January 5, 2025 • 5:00 PM ET
As of January 5, 2025 • 5:00 PM ET
Date/Time | Source | News Release |
---|---|---|
12/29/2024 04:06 PM EST | Stock Traders Daily | (AVTX) Proactive Strategies |
12/08/2024 11:12 AM EST | Stock Traders Daily | Trading (AVTX) With Integrated Risk Controls |
11/12/2024 09:09 AM EST | SeekingAlpha | Avalo Therapeutics receives $69.4M in proceeds from full exercise of private placement warrants |
11/08/2024 04:36 AM EST | US Earnings Reports | Expected earnings - Avalo Therapeutics Inc. |
11/07/2024 09:34 AM EST | SeekingAlpha | Avalo Therapeutics GAAP EPS of -$2.83, revenue of $0.25M |
11/06/2024 08:02 AM EST | Stock Traders Daily | Where are the Opportunities in (AVTX) |
09/13/2024 03:56 PM EDT | Stock Traders Daily | How To Trade (AVTX) |
08/29/2024 04:22 AM EDT | Stock Traders Daily | Trading (AVTX) With Integrated Risk Controls |
08/26/2024 10:00 AM EDT | QM US Market Movers News | US Companies Moving the Markets, Morning edition Mon, Aug 26, 2024 as of 10.00 am ET |
08/12/2024 07:26 AM EDT | SeekingAlpha | Avalo Therapeutics GAAP EPS of -$14.07 |
Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.